Abstract:Objective To identify the clinical features, the molecular diagnosis and the molecular mechanism of three unrelated factor X deficiency families. Methods Three probands were male and the diagnosis was validated by coagulant parameters. The F X coagulation activity ( F X∶ C ) and antigen (FX∶ Ag) were tested by clotting test and ELISA method. The cross-corrected test was used to rule out the inhibitor of FX in plasma. Thrombin generation test was evaluated. The antigen and the molecule weight of the FX in plasma were measured with western blotting. Gene mutations were analyzed in the probands and their family members with PCR and DNA sequencing. FX expression plasmids were constructed and transientby being transfected into 293T cells. FX: C and FX: Ag of the expression products were tested. Results APTT and PT in proband 1 were obviously prolonged, 113.4 s and 62.3 s, respectively. And there was no inhibitor in plasma. The thrombin generation was lower compared to normal reference. APTT and PT in proband 2 were 56. 5 s and 28.7 s. There was no inhibitor in the plasma. The thrombin generation was 1 101.5 nmol · min. APTT and PT in proband 3 were 117.3 s and 44. 3 s. The thrombin generation was 782.5 nmol · min. FX∶ C and FX∶ Ag in proband 1 were 1.4% and 3.6%, with a homozygous mutation in FX gene (Ser425→Pro). In vitro expression of the mutation showed a normal synthesis in the cell but secretion dysfuntion. In proband 2 F X: C and F X: Ag were 2. 2% and 5. 5%, with two heterozygous mutations in FX gene (Ala-29→Pro and Phe324→Leu). The Ala-29 → Pro mutation led to significantly reduced expressions of FX in both cell lysate and cell culture supernatants compared to wild-type plasmid,(41.32 ±5.21 )% and(6. 30 ± 1.84)% respectively. However Phe324→Leu mutation almost did not affect the FX synthesis. FX: C and FX: Ag in proband 3 were 2. 2% and 35%, with two heterozygous mutations in FX gene( Ala235→Thr and Arg347→Cys). The expressions of these two mutant FX proteins in cell lysate were similar to those of wild-type but obviously lower in the supernatant. Conclusions Five mutations of F X gene are found in this study. These mutations (Ser425Pro, Phe324Leu, Ala235Thr and Arg347Cys)can not affect F X protein synthesis. However Ala-29Pro mutation can reduce F X protein synthesis and cause secretion dysfunction.

Inherited coagulation factor X deficiency caused by two novel mutations in factor X gene]

A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree

Factor X Deficiency Resulted from a Missense Mutation Thr318Met in the FX Gene

[The Inherited Coagulation Factor XI Deficiency Caused by Intronic Mutation IVS J-4delgttg].

Study on the molecular mechanism of the inherited factor X deficiency in three unrelated families

Molecular Defects in the Factor X Gene Caused by Novel Heterozygous Mutations IVS5+1G>A and Asp409del.

Genetic Analysis of a Pedigree with Combined Factor XII and Factor XI Deficiency

[FXI Gene Mutations in Two Pedigrees of Congenital Clotting Factor XI Deficiency].

Severe hereditary coagulation factor V deficiency caused by two novel heterozygous mutations]

A Novel Factor X Gene Mutation Val (GTC) 384ala (GCC) in a Chinese Family Resulting in Congenital Factor X Deficiency.

Molecular analysis of the discrepancy between the genotypes and phenotypes in a inherited coagulation factor Ⅶ deficiency.

Severe Coagulation Factor X Deficiency Caused by Two De Novel Heterozygous Missense Mutations in Factor X Gene

[Inherited Coagulation Factor VII Deficiency Caused by Double Heterozygotic Mutations Arg304Gln and Arg304Trp].

Compound Heterozygous Nonsense Mutations Leading to Hereditary Deficiency of Coagulation Factor XI in a Chinese Pedigree

[Identification of Two Novel Mutation in Two Chinese Hereditary Coagulation Factor XIII Deficiency Families].

[Double Heterozygous Mutations of Non-Canonical Splice (ivs1a + 5g > A) and His348Gln Caused Inherited Coagulation Factor VII Deficiency].

[Two Novel Mutations in One Pedigree with Hereditary Factor VII Deficiency].

Two Novel Factor V Gene Mutations Associated with Congenital Coagulation Factor V Deficiency, Study of One Pedigree

[Molecular Genetic Analysis for a Pedigree with Severe Hereditary Coagulation Factor VII Deficiency].

Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency

[Studies on Inherited Coagulation Factor VII Deficiency and Tissue Factor Abnormality in a Pedigree].